UY23624A1 - Procedimiento para la preparacion de nuevos derivados de indol - Google Patents
Procedimiento para la preparacion de nuevos derivados de indolInfo
- Publication number
- UY23624A1 UY23624A1 UY23624A UY23624A UY23624A1 UY 23624 A1 UY23624 A1 UY 23624A1 UY 23624 A UY23624 A UY 23624A UY 23624 A UY23624 A UY 23624A UY 23624 A1 UY23624 A1 UY 23624A1
- Authority
- UY
- Uruguay
- Prior art keywords
- alkyl group
- preparation
- represented
- disorders
- indeol
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- WKEMJKQOLOHJLZ-UHFFFAOYSA-N Almogran Chemical compound C1=C2C(CCN(C)C)=CNC2=CC=C1CS(=O)(=O)N1CCCC1 WKEMJKQOLOHJLZ-UHFFFAOYSA-N 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000016285 Movement disease Diseases 0.000 abstract 1
- 206010043269 Tension headache Diseases 0.000 abstract 1
- 208000008548 Tension-Type Headache Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 238000006114 decarboxylation reaction Methods 0.000 abstract 1
- ADNRKDVOJHKCQN-UHFFFAOYSA-N ethyl 4-[[3-[2-(dimethylamino)ethyl]-1h-indol-5-yl]methylsulfonyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OCC)CCN1S(=O)(=O)CC1=CC=C(NC=C2CCN(C)C)C2=C1 ADNRKDVOJHKCQN-UHFFFAOYSA-N 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- -1 methoxy, benzyl Chemical group 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Processing Of Solid Wastes (AREA)
- Fertilizers (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Un procedimiento para la preparación de un compuesto de fórmula (I), representado en la figura 1, y sales farmacéuticamente aceptables de los mismos, incluyendo procedimientos de descarboxilación de un ácido carboxílico como el de fórmula (VI) representado en la figura 2, donde: R1 y R2 representan cada uno un átomo de hidrógeno o un grupo alquilo; Z representa un anillo de los representados en la figura 3, donde n es 4, 5 o 6; R3 representa un hidrógeno o un grupo alquilo; R4 representa un grupo alquilo, metoxi, bencilo o R5NHCO, con R5 siendo un grupo alquilo; R6 representa un grupo alquilo. Ejemplos no limitantes: 1-[[3-(2-dimetilaminoetil)-5-indolil]metanosulfonil]pirrolidina; 1-[[3-(2-dimetilaminoetil)-5-indolil]metanosulfonil]-4-etoxicarbo-nil piperacina; o cualquier sal hidroclorhídrica de ellos. Las composiciones farmacéuticas de estos compuestos son útiles para el tratamiento de desórdenes del cuerpo humano, como desórdenes del movimiento, depresión, ansiedad, migraña, desórdenes de cefalea tensional, entre otros.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929216009A GB9216009D0 (en) | 1992-07-28 | 1992-07-28 | New indol derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY23624A1 true UY23624A1 (es) | 1993-08-10 |
Family
ID=10719423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY23624A UY23624A1 (es) | 1992-07-28 | 1993-07-28 | Procedimiento para la preparacion de nuevos derivados de indol |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US5565447A (es) |
| EP (1) | EP0605697B1 (es) |
| JP (1) | JP2716585B2 (es) |
| KR (1) | KR100191830B1 (es) |
| CN (1) | CN1035179C (es) |
| AT (1) | ATE177080T1 (es) |
| BR (2) | BR9305589A (es) |
| CA (1) | CA2120028C (es) |
| CZ (1) | CZ282659B6 (es) |
| DE (2) | DE10199016I2 (es) |
| DK (1) | DK0605697T3 (es) |
| EC (1) | ECSP930953A (es) |
| EG (1) | EG20340A (es) |
| FI (1) | FI109998B (es) |
| GB (1) | GB9216009D0 (es) |
| GR (1) | GR3029915T3 (es) |
| HK (1) | HK1011680A1 (es) |
| HU (2) | HUT70518A (es) |
| IL (1) | IL106387A (es) |
| LU (1) | LU90758I2 (es) |
| MX (1) | MX9304524A (es) |
| MY (1) | MY113266A (es) |
| NL (1) | NL300053I2 (es) |
| NO (1) | NO180231C (es) |
| NZ (1) | NZ254152A (es) |
| PL (1) | PL174352B1 (es) |
| RU (1) | RU2117667C1 (es) |
| SG (1) | SG48708A1 (es) |
| TW (1) | TW235297B (es) |
| UA (1) | UA27818C2 (es) |
| UY (1) | UY23624A1 (es) |
| WO (1) | WO1994002460A1 (es) |
| ZA (1) | ZA935316B (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2712591B1 (fr) * | 1993-11-19 | 1996-02-09 | Pf Medicament | Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique. |
| FR2731224B1 (fr) * | 1995-03-02 | 1997-05-30 | Pf Medicament | Nouveaux derives bi-tryptaminiques sulfonamides, leur procede de preparation et leur utilisation a titre de medicaments |
| GB9523462D0 (en) * | 1995-11-16 | 1996-01-17 | Merck Sharp & Dohme | Therapeutic agents |
| US8022095B2 (en) | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
| US6310066B1 (en) | 1998-04-29 | 2001-10-30 | American Home Products Corp. | Antipsychotic indolyl derivatives |
| US6204274B1 (en) | 1998-04-29 | 2001-03-20 | American Home Products Corporation | Indolyl derivatives as serotonergic agents |
| US6066637A (en) * | 1998-06-19 | 2000-05-23 | American Home Products Corporation | Indolyl derivatives as serotonergic agents |
| GB0302094D0 (en) | 2003-01-29 | 2003-02-26 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| GB0324269D0 (en) | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| WO2006129190A1 (en) * | 2005-06-03 | 2006-12-07 | Glenmark Pharmaceuticals Limited | Process for the preparation of almotriptan |
| US20070112055A1 (en) * | 2005-09-30 | 2007-05-17 | Glenmark Pharmaceuticals Limited | Crystalline forms of almotriptan and processes for their preparation |
| DE102006027229A1 (de) * | 2006-06-09 | 2007-12-20 | Grünenthal GmbH | 1,3-Disubstituierte 4-Methyl-1H-pyrrol-2-carbonsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln |
| AU2007310949A1 (en) | 2006-10-19 | 2008-04-24 | Auspex Pharmaceuticals, Inc. | Substituted indoles |
| TWI321616B (en) | 2007-03-27 | 2010-03-11 | Coretronic Corp | Centrifugal blower |
| CZ302424B6 (cs) * | 2007-06-13 | 2011-05-11 | Zentiva, A. S. | Zpusob prípravy almotriptanu o vysoké cistote |
| CN101842352A (zh) * | 2007-08-02 | 2010-09-22 | 基因里克斯(英国)有限公司 | 新方法 |
| CN103724252A (zh) * | 2012-10-12 | 2014-04-16 | 苏州四同医药科技有限公司 | 一种阿莫曲坦的制备方法 |
| EP3766483A1 (en) | 2019-07-19 | 2021-01-20 | BioPharma Synergies, S. L. | Orodispersible powder composition comprising a triptan |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2082175B (en) * | 1980-08-12 | 1984-05-02 | Glaxo Group Ltd | Heterocyclic compounds |
| GR79215B (es) * | 1982-06-07 | 1984-10-22 | Glaxo Group Ltd | |
| GB2162532B (en) * | 1984-08-04 | 1988-08-03 | Ritchie Swanson John | Decontaminant wash composition |
| GB8431426D0 (en) * | 1984-12-13 | 1985-01-23 | Glaxo Group Ltd | Chemical compounds |
| GB8719167D0 (en) * | 1987-08-13 | 1987-09-23 | Glaxo Group Ltd | Chemical compounds |
| YU48855B (sh) * | 1990-06-07 | 2002-06-19 | The Wellcome Foundation Limited | Heterociklična jedinjenja i njihovi derivati koji su modifikatori dejstva 5-hidroksi-triptamina i postupak njihovog dobijanja |
-
1992
- 1992-07-28 GB GB929216009A patent/GB9216009D0/en active Pending
-
1993
- 1993-07-19 RU RU94020400A patent/RU2117667C1/ru active
- 1993-07-19 EP EP93915953A patent/EP0605697B1/en not_active Expired - Lifetime
- 1993-07-19 WO PCT/EP1993/001901 patent/WO1994002460A1/en active IP Right Grant
- 1993-07-19 DE DE2001199016 patent/DE10199016I2/de active Active
- 1993-07-19 PL PL93302917A patent/PL174352B1/pl unknown
- 1993-07-19 JP JP6504146A patent/JP2716585B2/ja not_active Expired - Lifetime
- 1993-07-19 BR BR9305589A patent/BR9305589A/pt not_active Application Discontinuation
- 1993-07-19 DE DE69323712T patent/DE69323712T2/de not_active Expired - Lifetime
- 1993-07-19 AT AT93915953T patent/ATE177080T1/de active
- 1993-07-19 CA CA002120028A patent/CA2120028C/en not_active Expired - Lifetime
- 1993-07-19 NZ NZ254152A patent/NZ254152A/en not_active IP Right Cessation
- 1993-07-19 UA UA94005336A patent/UA27818C2/uk unknown
- 1993-07-19 SG SG1996000062A patent/SG48708A1/en unknown
- 1993-07-19 IL IL106387A patent/IL106387A/xx not_active IP Right Cessation
- 1993-07-19 CZ CZ94664A patent/CZ282659B6/cs not_active IP Right Cessation
- 1993-07-19 DK DK93915953T patent/DK0605697T3/da active
- 1993-07-19 HU HU9400869A patent/HUT70518A/hu unknown
- 1993-07-19 KR KR1019940700865A patent/KR100191830B1/ko not_active IP Right Cessation
- 1993-07-21 TW TW082105804A patent/TW235297B/zh not_active IP Right Cessation
- 1993-07-22 ZA ZA935316A patent/ZA935316B/xx unknown
- 1993-07-26 EC EC1993000953A patent/ECSP930953A/es unknown
- 1993-07-27 MX MX9304524A patent/MX9304524A/es active IP Right Grant
- 1993-07-28 UY UY23624A patent/UY23624A1/es not_active IP Right Cessation
- 1993-07-28 EG EG47893A patent/EG20340A/xx active
- 1993-07-28 MY MYPI93001483A patent/MY113266A/en unknown
- 1993-07-28 CN CN93109364A patent/CN1035179C/zh not_active Expired - Lifetime
-
1994
- 1994-03-22 NO NO941019A patent/NO180231C/no not_active IP Right Cessation
- 1994-03-25 FI FI941413A patent/FI109998B/fi not_active IP Right Cessation
-
1995
- 1995-05-09 US US08/437,682 patent/US5565447A/en not_active Expired - Lifetime
- 1995-06-30 HU HU95P/P00696P patent/HU211243A9/hu unknown
-
1996
- 1996-10-10 BR BR1100061-9A patent/BR1100061A/pt active IP Right Grant
-
1998
- 1998-12-02 HK HK98112654A patent/HK1011680A1/xx not_active IP Right Cessation
-
1999
- 1999-04-07 GR GR990401006T patent/GR3029915T3/el unknown
-
2001
- 2001-04-11 LU LU90758C patent/LU90758I2/fr unknown
- 2001-08-21 NL NL300053C patent/NL300053I2/nl unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY23624A1 (es) | Procedimiento para la preparacion de nuevos derivados de indol | |
| ATE13422T1 (de) | Derivate von 1-aryl-2-aminomethyl-cyclopropancarboxamiden (z), ihre herstellung und ihre verwendung fuer die behandlung von stoerungen des zentralnervensystems. | |
| PT98393A (pt) | Processo para a preparacao de derivados de quinuclidina | |
| NZ225820A (en) | Piperidyl substituted indole derivatives and pharmaceutical compositions | |
| ATE185345T1 (de) | 1,4-disubstituierte piperazine zur behandlung von erkrankungen des zentralnervensystems und von nervenendokrinen erkrankungen | |
| AR036659A1 (es) | Compuestos derivados de fenil-piperazina, fenil-piperidina y fenil-tetrahidropiridina como inhibidores de la reabsorcion de la serotonina, una composicion farmaceutica y utilizacion de los mismos para la preparacion de medicamentos | |
| AR002967A1 (es) | Esteres y amidas de la 1,4-piperidina disustituida, sus sales de acidos aceptables desde el punto de vista fisiologico, un procedimiento para supreparacion y las preparaciones farmaceuticas que los/las contienen. | |
| AR035235A1 (es) | Derivados heterocicliloxi-,-tioxi- y -aminobenzazol como ligandos de 5-hidroxitriptamina-6, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos derivados para la manufactura de un medicamento | |
| ES2094742T3 (es) | Aminocarbonilcarbamatos relacionados con fisostigmina, un procedimiento para su preparacion y su uso como medicamentos. | |
| IT1190793B (it) | Composti attivi nel trattamento dell'ulcera e sintomi allergici della pelle | |
| HUP0203118A2 (hu) | Béta-diszubsztituált metalloproteáz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| IS3961A (is) | Indolafleiður, aðferð til framleiðslu þeirra og notkunar sem lyfja | |
| IT1250362B (it) | Derivati dell'1-3-diossolano quali agenti per la riduzione del colesterolo | |
| MX9303422A (es) | Benzodiazepinas, procedimiento para su preparacion y medicamento que las contiene. | |
| AR035682A1 (es) | Piperazinilcarbonilquinolinas e -isoquinolinas, un proceso para su preparacion, las preparaciones farmaceuticas que las contienen, el uso de las mismas para preparar un medicamento, los antagonistas selectivos del receptor de 5-ht2a que conforman estos compuestos y el uso de estos antagonistas en la | |
| EA200500023A1 (ru) | N,n-дизамещенные диазоциклоалканы, используемые для лечения заболеваний центральной нервной системы (цнс), вызываемых серотонинергической дисфункцией | |
| UY23524A1 (es) | Derivados del indol | |
| PE20030088A1 (es) | Compuestos arilicos sustituidos con quinuclidinas para el tratamiento de enfermedades | |
| ES2056025B1 (es) | Nuevos derivados de indol. | |
| UY25253A1 (es) | Compuestos de eteres cíclicos de piperidinilaminometil trifluorometilo como antagonistas de la sustancia p | |
| TH15125A (th) | อนุพันธ์อินดอลชนิดใหม่ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| VENC | Patent expired |
Effective date: 20131201 |